Cell and Gene Therapy Bio-Manufacturing Market Global Report 2026: Market to Surge to $21.46 Billion by 2030 as Thermo Fisher Scientific, Merck KGaA, Lonza and Samsung Biologics Accelerate Automation

Boost ROI with scalable viral-vector platforms, automated single-use processing, digital quality control, and expanded CDMO capacity through partnerships and acquisitions.Dublin, Oct. 01, 2026 (GLOBE NEWSWIRE) -- "Cell and Gene Therapy Bio-Manufacturing Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global cell and gene therapy biomanufacturing market is experiencing rapid expansion as advanced therapies move from research and clinical development toward comm